Translate
About
Tvrd (NASDAQ:TVRD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 2 2026
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
Mar 31 2026
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Feb 12 2026
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
Jan 8 2026
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Jan 8 2026
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
Financials
Revenue
$0
Market Cap
$27.77 M
EPS
-3.26